Ovarian cancer symptoms: The ‘patchy’ rash on your skin you should never ignore
OVARIAN CANCER symptoms may be difficult to spot in its early stages, but can include stomach bloating and passing more urine than normal. You could also be at risk of ovarian cancer if you develop this unusual rash on your skin. Should you consider speaking to a doctor? (Source: Daily Express - Health)
Source: Daily Express - Health - September 17, 2020 Category: Consumer Health News Source Type: news

The Lancet: Many countries falling behind on global commitments to tackling premature deaths from chronic diseases, such as diabetes, lung cancer and heart disease
(The Lancet) Around the world, the risk of dying prematurely from preventable and largely treatable chronic diseases such as stroke, heart disease, and stomach cancer has declined steadily over the past decade, but death rates from other chronic diseases such as diabetes, lung cancer, colon cancer, and liver cancer are declining too slowly or worsening in many countries. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 3, 2020 Category: International Medicine & Public Health Source Type: news

How the COVID-19 Pandemic Has Changed Cancer Care, In 4 Charts
Before the pandemic, about 1,000 new patients came to Boston’s Dana-Farber Cancer Institute for treatment consultations each week. When COVID-19 hit Massachusetts this spring, the number of new consultations fell by half and the hospital moved as many appointments as possible online. Now, with daily case counts relatively low in the area, the hospital is back to scheduling about 800 consultations per week, using a mixture of telemedicine and in-person appointments, says associate chief medical officer Dr. Andrew Wagner—but that still means about 200 cancer patients per week are not getting the treatment consult...
Source: TIME: Health - August 28, 2020 Category: Consumer Health News Authors: Jamie Ducharme and Emily Barone Tags: Uncategorized COVID-19 Source Type: news

Immune protein IL-17A responsible for lethal side effects of gastric cancer
(Kanazawa University) The formation of scar tissue, or fibrosis, as gastric cancer disseminates throughout the peritoneum can be more lethal than the cancer itself and can interfere with chemotherapy. Researchers from Kanazawa University have now found that proinflammatory cytokine IL-17A from mast cells heavily influences the degree of fibrosis and causes structural changes in peritoneal cells. Preventing mast cells from releasing IL-17A may therefore be a promising treatment strategy for gastric cancer patients with peritoneal dissemination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 26, 2020 Category: Cancer & Oncology Source Type: news

Bowel cancer warning: Does your poo sink or float? Hidden signs of a tumour in the toilet
BOWEL cancer symptoms include weight loss, stomach pain, and feeling very tired for no obvious reason. But you could also be at risk of the disease if you notice small changes to your daily toilet routine. Does your poo sink or float? These are the hidden signs of bowel cancer you should look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - August 24, 2020 Category: Consumer Health News Source Type: news

Small change makes cancer vaccine more effective in animal tests
(Thomas Jefferson University) Tweaking the adenovirus spike protein induces a more robust immune reaction for a cancer vaccine against gastric, pancreatic, esophageal and colon malignancies in animal models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2020 Category: International Medicine & Public Health Source Type: news

Molecule secreted by cancer-associated fibroblasts promotes anticancer drug resistance
(Kumamoto University) Joint research at Kumamoto University in Japan discovered a new mechanism for anticancer drug resistance in gastric cancer. Experiments clarified that the Annexin A6 molecule contained in extracellular vesicles (EVs) is secreted by cancer-associated fibroblasts (CAFs) and taken up by gastric cancer cells, resulting in resistance to anticancer drug treatment. New drug development that targets Annexin A6 and cancer-associated fibroblasts (CAFs) may be possible. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 21, 2020 Category: Cancer & Oncology Source Type: news

First US clinical trial testing efficacy of delivering aerosolized chemotherapy
(City of Hope) City of Hope surgical researchers are the first in the nation to open a clinical trial that could one day become an effective way to deliver chemotherapy to abdominal cancer patients who currently have very few treatment options. Ovarian, uterine, gastric and colorectal cancers can be difficult to treat using traditional intravenous chemotherapy, especially when the tumors spread to a thin layer of tissue that lines the abdomen called the peritoneum. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 11, 2020 Category: Cancer & Oncology Source Type: news

New method to help spot gastric cancer cells
(Chinese Academy of Sciences Headquarters) Researchers from the Shenyang Institute of Automation (SIA) of the Chinese Academy of Science (CAS) and City University of Hong Kong (CityU), in cooperation with doctors from the First Hospital of China Medical University, jointly proposed an optically induced electrokinetics (OEK) microfluidic method for label-free separation and characterization of gastric cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 5, 2020 Category: Cancer & Oncology Source Type: news

Is TAS-118 Plus Oxaliplatin a New Standard First-Line Therapy for Advanced Gastric Cancer in Asians? Is TAS-118 Plus Oxaliplatin a New Standard First-Line Therapy for Advanced Gastric Cancer in Asians?
TAS-118 plus oxaliplatin was more effective than S-1 plus cisplatin in a phase 3 trial and could be considered a new first-line treatment for advanced gastric cancer in Asian patients, researchers suggest.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

FDA approves Roche ’s new VENTANA HER2 Dual ISH test as companion diagnostic to identify breast cancer patients eligible for targeted therapy
Basel, 29 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay for the detection of the HER2 biomarker in breast cancer and as a companion diagnostic for Herceptin (trastuzumab) therapy. HER2 - human epidermal growth factor receptor 2 - is an important biomarker sometimes found in breast cancers.2 Its detection and inhibition can help healthcare professionals more effectively manage this aggressive cancer. The VENTANA HER2 Dual ISH DNA Probe Cocktail assay is designed to be completed within the same day, enabl...
Source: Roche Investor Update - July 29, 2020 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s new VENTANA HER2 Dual ISH test as companion diagnostic to identify breast cancer patients eligible for targeted therapy
Basel, 29 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay for the detection of the HER2 biomarker in breast cancer and as a companion diagnostic for Herceptin (trastuzumab) therapy. HER2 - human epidermal growth factor receptor 2 - is an important biomarker sometimes found in breast cancers.2 Its detection and inhibition can help healthcare professionals more effectively manage this aggressive cancer. The VENTANA HER2 Dual ISH DNA Probe Cocktail assay is designed to be completed within the same day, enabl...
Source: Roche Media News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Epstein-Barr virus rewires host epigenomes to drive stomach cancer
(Duke-NUS Medical School) Researchers in Japan and Singapore have discovered a molecular mechanism that explains how Epstein-Barr virus (EBV) infection alters a host's epigenome to promote tumorigenesis (the transformation of normal cells into cancer cells) in certain types of stomach cancer. The findings suggest that EBV infection plays an important role in the development of EBV-associated stomach cancers, and provide fresh insights that may lead to new therapies for stomach and other virus-related malignancies. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 27, 2020 Category: Biology Source Type: news

Stomach cancer symptoms: The warning sign to look for when you go to the toilet
STOMACH cancer, otherwise known as gastric cancer, is a real threat to people over the age of 75. Look out for this warning sign when you go to the toilet. It could be a symptom of the deadly disease. (Source: Daily Express - Health)
Source: Daily Express - Health - July 26, 2020 Category: Consumer Health News Source Type: news

AI spots cervical cancer lymph node metastasis on MRI
An artificial intelligence (AI) algorithm was able to preoperatively identify...Read more on AuntMinnie.comRelated Reading: Textural analysis improves breast MRI's accuracy ASTRO releases first cervical cancer guidelines Model predicts metastases in endometrial cancer patients Caution urged for breast MRI evaluation of lymph nodes AI may predict lymph node metastasis in gastric cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 24, 2020 Category: Radiology Source Type: news